News
4317 posts · page 7 of 180
RVU Cuts Strain Electrophysiology: Financial Viability at Risk
Cuts to RVUs in electrophysiology challenge financial stability, prompting urgent discussions.
Innovative Approaches in Dermatomyositis Treatment Explored
Experts discuss breakthroughs at the intersection of rheumatology and dermatology.
Booster Shots Reduce Hospitalization Risk for Rheumatic Patients
Booster vaccines significantly decrease COVID-19 hospitalization rates in patients with rheumatic diseases, offering vital protection.
Fortrea Acquires Key Operations from Worldwide Clinical Trials
Fortrea is set to expand its capabilities by acquiring clinical and lab operations from Worldwide Clinical Trials.
Advancing Drug Development with Integrated PK/PD and Metabolism Approaches
New strategies in pharmacokinetics and pharmacodynamics promise to enhance drug development efficiency and safety.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 After IPO
Molbio Diagnostics swings to Rs 52.7 crore profit in Q1, boosted by Truenat test-kit sales.
Indian AI Tool for Cancer Care Spotlighted at BRICS Health Summit
iOncology.ai, developed by AIIMS and C-DAC, gains attention for its potential to transform cancer care in emerging economies.
Waystar Considers Sale Amid Declining Market Valuation
Waystar, a healthcare software firm, is exploring strategic options, including a sale, as its market value drops.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, enhancing its diagnostics division.
Global Experts Conclude International Nuclear Medicine Congress in Tabriz
The International Nuclear Medicine Congress concluded in Tabriz, focusing on advances in nuclear imaging and patient care.
Therapeutic Nuclear Medicine Market to Expand at 4.2% CAGR by 2034
The therapeutic nuclear medicine market is projected to grow at a 4.2% CAGR from 2025 to 2034, driven by advancements in treatment options.
Early Surgery Key in Complex Craniofacial Trauma Case
A multidisciplinary team successfully managed severe craniofacial trauma using early surgery and osteosynthesis.
Dr. Jonathan Burke Appointed Head of NIH Dental Research Body
Dr. Jonathan Burke will lead the National Institute of Dental and Craniofacial Research, bringing his expertise to NIH's dental research initiatives.
New Advances in Dry Eye Treatments Poised for 2025 Launch
Emerging therapies for dry eye disease promise enhanced patient relief by 2025.
Highlights from the 26th EURETINA Congress in Vienna
The 26th EURETINA Congress in Vienna showcased groundbreaking advancements in retinal care and research.
ESCRS 2026 Eyes Inclusive Workplaces for Ophthalmology
ESCRS 2026 focuses on fostering respectful, inclusive environments in ophthalmology, highlighting diversity and equality.
Molbio Diagnostics Reports Rs 52.7 Crore Profit in Q1 Following IPO
Molbio Diagnostics recorded a Rs 52.7 crore profit in Q1, a turnaround from last year's loss, driven by Truenat test-kit demand.
iOncology.ai: Indian AI Platform for Cancer Care Spotlighted at BRICS
iOncology.ai, an AI platform for cancer care, gains recognition in BRICS Health Journal, highlighting its potential impact on global healthcare.
Waystar Considers Sale Amidst Falling Valuation, Sources Reveal
Healthcare software firm Waystar explores a potential sale as its market value declines, according to sources.
GE HealthCare Eyes $1 Billion Acquisition of Sofie Biosciences
GE HealthCare is negotiating a $1 billion acquisition of Sofie Biosciences, a leader in radiopharmaceuticals for cancer diagnostics.
Molbio Diagnostics Reports Rs 52.7 Cr Profit Post-IPO Success
Molbio Diagnostics swings to Rs 52.7 crore profit in Q1, buoyed by Truenat test-kit sales after recent IPO.
iOncology.ai: Indian AI Tool for Cancer Care Shines at BRICS Summit
iOncology.ai, an AI-driven cancer care platform by AIIMS and C-DAC, gains international attention at the BRICS Summit.
Waystar Weighs Sale Two Years After IPO Amid Software Sector Slump
Healthcare software firm Waystar considers sale options, hiring Evercore amid a market downturn.
Rare Gene Elevates Lung Cancer Risk in Non-Smokers in Appalachia
A gene mutation linked to lung cancer risk is prevalent in Southern Appalachia, posing a threat to non-smokers.